Device Trial Radar · NCT01601496
Evaluation of FUSION™ Vascular Graft for Above Knee Targets
Last checked: Nov 20, 2026Latest source record: Oct 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
117
Actual
Start
Oct 26, 2009
Primary completion
Jul 24, 2013
Study completion Jul 24, 2013
Sponsor
- Lead sponsor
- Maquet CardiovascularNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 18, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the post-market study was to evaluate the safety and performance of the FUSION Vascular Graft.
Conditions
- Peripheral Arterial Occlusive Disease (PAOD)
Interventions
FUSION Vascular GraftDevice
All subjects who received the FUSION Vascular Graft at the baseline implant procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Participants With Primary Graft Patency at 12 MonthsTime frame: 12 Months
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
Wilhelminenspital Vienna
Vienna, Austria
Klinikum Darmstadt
Darmstadt, Germany
Universitätsklinikum Frankfurt
Frankfurt am Main, Germany
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.